Institute for Molecular Medicine Finland (FIMM) Email Format
Research ServicesSouthwest Finland, Finland201-500 Employees
Institute for Molecular Medicine Finland (FIMM) is an international research institute based in Helsinki, in the Southwest Finland region of Finland, with a focus on human genomics and personalized medicine. The organization integrates molecular medicine research, a technology center, and biobanking infrastructure within a single campus to support translational science and the adoption of personalized medicine in health care. It is a mid-sized institution operating in the research services sector with a global outlook. A notable recent development is a 2024 partnership with Vaxine Pty Ltd to pursue a vaccine intended to stimulate antibodies that target beta-amyloid proteins in the brain.